U.S. Logistics Stock News

NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel (INTC) Valuation Check After New AI Investment And Data Center Momentum

Intel (INTC) is back in focus after committing at least US$100 million to AI chip startup SambaNova Systems. CEO Lip-Bu Tan also outlined strong AI driven server CPU demand, along with improving foundry yields and rising customer interest. See our latest analysis for Intel. Those AI focused updates are landing at a time when Intel’s share price has been volatile in the short term, with a 1 day share price return of 6.19% decline and a 7 day share price return of 4.30% decline. However, the 90...
NYSE:FMC
NYSE:FMCChemicals

What FMC (FMC)'s Weak Outlook, Junk Downgrade and Strategy Review Mean For Shareholders

FMC Corporation recently reported fourth-quarter 2025 and full-year results showing lower sales and a very large swing to a net loss, issued 2026 revenue guidance that implies a 5% decline at the midpoint, and filed an US$84.26 million shelf registration related to an ESOP share offering. At the same time, FMC’s board authorized a review of multiple strategic options while Moody’s cut the company’s debt rating to junk with a negative outlook, highlighting concerns around patent expirations...
NYSE:AES
NYSE:AESRenewable Energy

Assessing Whether AES (AES) Is Overvalued After Its Strong 1 Year Shareholder Return

AES stock performance snapshot AES (AES) has drawn attention after recent share price moves, with the stock showing gains over the past month and past 3 months alongside positive annual revenue and net income figures. See our latest analysis for AES. At a share price of $16.25, AES has seen momentum build recently, with a 30 day share price return of 13.48% and a 1 year total shareholder return of 67.93%, even though the 3 and 5 year total shareholder returns remain negative. If this move in...
NYSE:RACE
NYSE:RACEAuto

Ferrari (NYSE:RACE) Valuation Check After Sharp 1 Day Share Price Rebound

Recent Share Performance and Business Snapshot Ferrari (NYSE:RACE) shares closed at $363.22, with a 1 day return of 8.1% and a 7 day return of 10.0%, while the stock shows negative moves over the past month and past 3 months. Over longer horizons, Ferrari’s total return is negative over the past year but positive over the past 3 years and 5 years. Reported revenue stands at €7,146.0, with net income of €1,600.0, alongside annual revenue and net income growth figures that remain in positive...
NYSE:MLI
NYSE:MLIMachinery

Earnings Beat and Higher EPS Could Be A Game Changer For Mueller Industries (MLI)

Mueller Industries, Inc. reported past fourth-quarter 2025 earnings with sales of US$962.39 million and net income of US$153.71 million, alongside full-year sales of US$4.18 billion and net income of US$765.19 million, all higher than the prior year. An interesting takeaway is that both basic and diluted earnings per share from continuing operations rose for the quarter and the full year, pointing to improved profitability on a per-share basis. Next, we will examine how this improved...
NYSE:ONON
NYSE:ONONLuxury

New On Holding CFO Appointment Puts Spotlight On Valuation And Growth

On Holding (NYSE:ONON) has appointed Frank Sluis as its new Chief Financial Officer. The company announced the leadership change as a material update for investors and stakeholders. Sluis brings finance experience from major consumer focused businesses to the role. On Holding, known for its performance footwear and apparel, sits in a competitive global sportswear market where brand strength, product differentiation, and efficient supply chains matter for long term positioning. In that...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

A Look At Palomar Holdings (PLMR) Valuation After New US$450 Million Credit Facility And Q4 2025 Earnings Setup

Palomar Holdings (PLMR) heads into its Q4 2025 earnings release today at 4:00 PM Eastern, shortly after securing a new US$450 million unsecured credit facility that increases its financial flexibility and funding options. See our latest analysis for Palomar Holdings. The stock has picked up near term momentum, with a 1 day share price return of 2.14% and 7 day share price return of 6.04%. The 1 year total shareholder return of 17.16% sits against a much stronger 3 year total shareholder...
NasdaqGS:PI
NasdaqGS:PISemiconductor

Impinj (PI) Margins Story Emerges As FY 2025 Ends With TTM EPS Loss

Impinj FY 2025 Earnings Snapshot Sets Up a Margins Story for Investors Impinj (PI) has just wrapped up FY 2025 with Q4 revenue of US$92.8 million and a basic EPS loss of US$0.04, alongside trailing twelve month revenue of US$361.1 million and basic EPS of US$0.37 in losses. Over the past six quarters, the company has seen quarterly revenue move between US$74.3 million and US$97.9 million, while basic EPS has swung from a profit of US$0.40 in Q2 2025 to losses such as US$0.44 in Q3 2025 and...
NYSE:LB
NYSE:LBReal Estate

Is LandBridge (LB) Quietly Pivoting From Datacenters To A Pore Space Royalty Power Play?

In recent months, LandBridge Company LLC has drawn attention for highlighting that most of its revenue comes from surface use royalties tied to pore space, particularly through its relationship with WaterBridge, while recent acquisitions have expanded its pore space footprint. A key takeaway for investors is that LandBridge’s underlying value appears increasingly tied to its ownership of subsurface pore space rather than to datacenter development, positioning it as a differentiated play on...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Is Luckin Coffee (OTCPK:LKNC.Y) Pricing Reflect Its Coffee Market Momentum And Growth Prospects

If you are wondering whether Luckin Coffee's current price really reflects its business today, you are not alone. Many investors are asking the same question. The stock last closed at US$37.10, with returns of 6.3% over 7 days, 12.0% over 30 days, 4.8% year to date, 26.9% over 1 year and a very large gain over 5 years that is above 5x. Recent headlines around Luckin Coffee have focused on its position in China's coffee market and how the brand is competing for consumer attention. This helps...
NYSE:EE
NYSE:EEOil and Gas

A Look At Excelerate Energy (EE) Valuation As Earnings Surprise Expectations Drive Recent Interest

Why expectations around Excelerate Energy’s earnings are moving the stock Recent interest in Excelerate Energy (EE) is being driven by expectations around its upcoming earnings report on February 25, 2026, following a pattern of earnings surprises in recent quarters. See our latest analysis for Excelerate Energy. That backdrop of earnings optimism is lining up with strong recent momentum, with a 30 day share price return of 28.47%, a 90 day share price return of 44.19%, and a 3 year total...
NYSEAM:EVI
NYSEAM:EVITrade Distributors

EVI Industries (EVI) Q2 EPS Doubles Year On Year Testing Premium Growth Narrative

EVI Industries (EVI) has reported Q2 2026 revenue of US$115.3 million and basic EPS of US$0.16, alongside trailing 12 month revenue of US$427.1 million and EPS of US$0.49 that frame the latest quarter within a broader earnings picture. The company has seen quarterly revenue move from US$92.7 million in Q2 2025 to US$115.3 million in Q2 2026, with basic EPS over the same quarters shifting from US$0.08 to US$0.16 as trailing net profit margins eased from 1.8% to 1.5%. This sets up a results...
NYSE:JMIA
NYSE:JMIAMultiline Retail

Jumia Technologies Q4 Loss Narrows To US$10.3m Challenging Bearish Profitability Narratives

Jumia Technologies FY 2025 Earnings Snapshot Jumia Technologies (NYSE:JMIA) closed FY 2025 with fourth quarter revenue of US$61.4 million and a net income loss of US$10.3 million, while trailing twelve month revenue stood at US$188.9 million against a trailing loss of US$61.6 million. Over the last year, the company has seen quarterly revenue move from US$36.3 million in Q1 2025 to US$61.4 million in Q4, with trailing twelve month losses narrowing from US$99.1 million at the end of 2024 to...
NYSEAM:UAMY
NYSEAM:UAMYMetals and Mining

Is United States Antimony’s (UAMY) North American Expansion Redefining Its Critical Minerals Investment Story?

In recent days, United States Antimony Corporation announced that its Chairman and CEO, Gary C. Evans, appeared on Bloomberg Television’s Businessweek Daily to discuss a new joint venture tied to the company’s expanding critical minerals operations across the U.S., Mexico, and Canada. This comes as the company has grown into a roughly US$1.08 billion producer and processor of antimony, zeolite, and other critical minerals, highlighting how business expansion can compound investor outcomes...
NYSE:XYL
NYSE:XYLMachinery

Xylem (XYL) Margins Hold At 10.6% Net Level And Test Bullish Upside Narrative

Xylem (XYL) closed out FY 2025 with Q4 revenue of US$2.4b and basic EPS of US$1.37, on net income of US$335m, while trailing 12 month revenue stood at US$9.0b with basic EPS of US$3.93 supported by US$957m of net income. The company has seen revenue move from US$8.6b and basic EPS of US$3.67 on net income of US$890m in the prior trailing period to the latest US$9.0b and US$3.93 on US$957m. This sets up a story where investors are likely to focus on how steady margin progression and earnings...
NYSE:UNH
NYSE:UNHHealthcare

Is It Time To Reconsider UnitedHealth Group (UNH) After The Recent Share Price Slump

If you are wondering whether UnitedHealth Group is starting to look attractively priced, this article will walk through what the current share price might be implying about value. The stock last closed at US$273.22, with returns of a 3.9% decline over 7 days, a 20.6% decline over 30 days, an 18.8% decline year to date, a 47.6% decline over 1 year, a 41.4% decline over 3 years and an 8.7% decline over 5 years. Recent headlines around UnitedHealth Group have focused on the share price...
NasdaqGM:CDNA
NasdaqGM:CDNABiotechs

CareDx (CDNA) Valuation Check As ACROBAT AlloHeme Trial Data Heads To 2026 Tandem Meetings

Why the ACROBAT data presentation matters for CareDx CareDx (CDNA) is back in focus after announcing that full 24 month follow up data from its ACROBAT study of the AlloHeme relapse monitoring test will be presented at the 2026 Tandem Meetings in Salt Lake City. The ACROBAT trial tracks AlloHeme, an AI powered NGS blood test aimed at detecting relapse earlier than traditional methods in patients who have undergone allogeneic hematopoietic cell transplantation for conditions such as Acute...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Datadog (DDOG) Q4 Margins At 3.1% Test Bullish Profitability Narratives

Datadog (DDOG) has wrapped up FY 2025 with fourth quarter revenue of US$953.2 million and basic EPS of US$0.13, alongside net income of US$46.6 million. This puts a clear spotlight on how its topline and per share earnings are tracking as the year closes out. Over the past six quarters, revenue has moved from US$690.0 million in Q3 2024 to US$953.2 million in Q4 2025. Over the same period, quarterly basic EPS has ranged from US$0.15 in Q3 2024 to US$0.01 in Q2 2025 and then to US$0.13 in the...
NasdaqGS:FRD
NasdaqGS:FRDMetals and Mining

Friedman Industries (FRD) Q3 2026 Net Margin Improvement Tests Bearish Cash Flow Narratives

Friedman Industries Q3 2026 Earnings Snapshot Friedman Industries (FRD) has reported Q3 2026 results with total revenue of US$168.0 million, net income of US$3.0 million and basic EPS of US$0.43, setting the tone for another data heavy quarter for investors to assess. The company has seen quarterly revenue move from US$106.8 million in Q2 2025 to US$94.1 million in Q3 2025, then to US$129.2 million in Q4 2025, US$134.8 million in Q1 2026, US$152.4 million in Q2 2026 and US$168.0 million in Q3...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Arrowhead Joins S&P 400 As Profitability Shifts Investor Focus

Arrowhead Pharmaceuticals (NasdaqGS:ARWR) has been added to the S&P 400 index and its related sector indices. At the same time, the company has been removed from the S&P 600 index, shifting its classification within the S&P family. This index change reflects a reclassification of Arrowhead's market standing and may affect how index funds and ETFs hold the stock. Arrowhead Pharmaceuticals focuses on RNA interference based therapies, an area that has attracted steady attention as drug...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

How Analyst Optimism on Traffic and Pricing Trends Will Impact Fastly (FSLY) Investors

In the past week, Fastly drew attention ahead of its latest earnings release, with analysts reiterating forecasts after the company previously reported US$158.2 million in quarterly revenue, up 15.3% year on year and above expectations. Recent analyst commentary has highlighted steady estimates, a generally cautious but positive tone on traffic growth and pricing, and Fastly’s record of usually meeting or beating revenue forecasts as key reasons investors are closely watching the upcoming...
NasdaqGS:GT
NasdaqGS:GTAuto Components

Goodyear Tire & Rubber (GT) Q4 Profitability Rebound Tests Bearish Loss And Debt Narratives

Goodyear Tire & Rubber (GT) has wrapped up FY 2025 with fourth quarter revenue of US$4.9 billion and basic EPS of US$0.36, alongside net income excluding extra items of US$105 million. This sets a clear marker after a volatile year for earnings. Over the past six quarters, revenue has moved in a relatively tight band between US$4.3 billion and just under US$5.0 billion. Quarterly basic EPS has swung from a loss of US$7.62 in Q3 2025 to positive readings in Q1, Q2 and Q4, giving you a mixed...
NYSE:MAS
NYSE:MASBuilding

Masco (MAS) Margins Hold Near 10.7% And Reinforce Earnings Resilience Narrative

Masco (MAS) closed out FY 2025 with fourth quarter revenue of US$1.8 billion and basic EPS of US$0.81, alongside net income of US$165 million, setting the tone for how the full year’s performance lands with investors. Over the past four quarters, the company has seen revenue move from US$7.8 billion on a trailing basis in Q4 2024 to US$7.6 billion in Q4 2025, while trailing EPS shifted from US$3.77 to US$3.88. This provides a clear view of how the top and bottom lines have been tracking...
NYSE:LUMN
NYSE:LUMNTelecom

Lumen Technologies (LUMN) Is Down 8.0% After New CRO Hire And Ongoing Losses Reported

Lumen Technologies recently appointed former Cisco executive Jeff Sharritts as Executive Vice President and Chief Revenue Officer, while also reporting fourth-quarter 2025 sales of US$3,041 million and a net loss of US$2 million, alongside full-year 2025 sales of US$12.40 billion and a net loss of US$1.74 billion. This combination of a high-profile commercial leadership change and a move from prior profitability to continued losses highlights both execution challenges and efforts to reshape...